Upcoming Meetings: FDA's Obstetrics and Gynecology Devices Panel
This article was originally published in The Gray Sheet
FDA's Obstetrics and Gynecology Devices Panel: Meeting July 22 and 23 at the Gaithersburg Marriott in Gaithersburg, Maryland, and July 24 at 9200 Corporate Blvd., Rockville, Maryland. On July 22-23, the panel will discuss "appropriate recommended testing" for intrapartum electronic fetal monitoring. Also on July 23, the panel will consider a premarket approval application for an implantable stent "used for in utero treatment of fetal postvesicular uropathy" and a PMA "for a silicone barrier contraceptive device." Discussion of the contraceptive device will continue on July 24. For more information, contact FDA's Alfred Montgomery at 301/594-1180...
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.